Neuros Medical Receives $25M Growth Capital

Neuros Medical

Neuros Medical, an Aliso Viejo, CA-based bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life, received $25M in Growth Capital.

The round was led by Trinity Capital (NASDAQ: TRIN).

The company intends to use the funds to augment the recent equity raised and further scale operations to assist with their commercial launch.

Led by David Veino, President and CEO, Neuros Medical is a bioelectric technology company that has developed the Altius system for the treatment of chronic post-amputation pain (Phantom Limb Pain and Residual Limb Pain). The Altius System incorporates the company’s patented platform technology, On-Demand Bioelectric Nerve Block, which patients initiate as needed for targeted pain relief. The technology blocks sensory nerves and has the potential to alleviate pain in people with phantom limb and residual limb pain, fulfilling a significant need for patients. This system also has the potential to reduce drug dependency as existing treatment options are primarily limited to opioids and gabapentinoids.